Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Other healthcare services. Per the activity note to the FY2021 annual report, the company provides medical and aesthetic services. Founded on 30 August 2018. Wholly owned by George Sharikadze.
| Ratio | 2019 | 2020 | 2021 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 68.4% | 31.3% | 89.1% |
| EBITDA Margin | -443.6% | -33.9% | -66.6% |
| EBITDAR | -248 | -114 | -78 |
| EBITDAR Margin | -405.2% | -15.7% | -23.0% |
| EBIT Margin | -536.6% | -45.9% | -93.7% |
| Net Profit Margin | -536.6% | -33.9% | -68.4% |
| Operating Expense % of Sales | 512.0% | 65.2% | 155.7% |
| Returns | |||
| Return on Assets (ROA) | -24.9% | -21.2% | -25.0% |
| Return on Equity (ROE) | -25.5% | -21.5% | -25.4% |
| ROIC [EBIT / Invested Capital] | -26.1% | -30.4% | -35.8% |
| Leverage & debt balances | |||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | N/A | N/A | N/A |
| Equity-to-Assets | 97.8% | 98.7% | 98.4% |
| Net Debt | -29 | -51 | -28 |
| Cash & Equivalents | 29 | 51 | 28 |
| Total Debt | N/A | N/A | N/A |
| Liquidity & working capital | |||
| Current Ratio | 21.11x | 34.89x | 22.82x |
| Quick Ratio | 5.00x | 34.89x | 22.82x |
| Cash Ratio | 0.97x | 3.49x | 1.88x |
| Total Current Assets | 622 | 510 | 335 |
| Total Current Liabilities | 29 | 15 | 15 |
| Inventory | 475 | N/A | N/A |
| Trade Receivables | 0 | 445 | 271 |
| Trade Payables | 29 | 12 | 12 |
| Net Working Capital | 592 | 495 | 321 |
| Net Working Capital % of Revenue | 968.2% | 68.1% | 94.4% |
| Trade Working Capital | 445 | 433 | 259 |
| Trade Working Capital % of Revenue | 727.7% | 59.5% | 76.2% |
| Change in Trade Working Capital | N/A | -12 | -174 |
| Turnover & efficiency | |||
| Inventory Turnover | 0.04x | N/A | N/A |
| Days Inventory Outstanding (DIO) | 8958.2 | N/A | N/A |
| Receivables Turnover | 849.71x | 1.64x | 1.25x |
| Days Sales Outstanding (DSO) | 0.4 | 223.1 | 291.4 |
| Payables Turnover | 0.66x | 43.02x | 3.03x |
| Days Payable Outstanding (DPO) | 556.0 | 8.5 | 120.7 |
| Cash Conversion Cycle | 8402.6 days | 214.6 days | 170.8 days |
| Asset Turnover | 0.05x | 0.63x | 0.37x |
| Cash flow & dividends | |||
| Operating Cash Flow | -592 | -40 | N/A |
| Free Cash Flow (OCF − Capex proxy) | -1,178 | -83 | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →